Annamalai Alagappan, Wisdom Lauren, Herada Megan, Nourredin Mazen, Ayoub Walid, Sundaram Vinay, Klein Andrew, Nissen Nicholas
Alagappan Annamalai, Lauren Wisdom, Megan Herada, Mazen Nourredin, Walid Ayoub, Vinay Sundaram, Andrew Klein, Nicholas Nissen, Comprehensive Transplant Center, Cedars Sinai Medical Center, Los Angeles, CA 90048, United States.
World J Hepatol. 2016 Oct 8;8(28):1182-1193. doi: 10.4254/wjh.v8.i28.1182.
Cirrhosis is a major cause of morbidity and mortality worldwide with liver transplantations as it only possible cure. In the face of a significant organ shortage many patients die waiting. A major complication of cirrhosis is the development of portal hypertension and ascites. The management of ascites has barely evolved over the last hundred years and includes only a few milestones in our treatment approach, but has overall significantly improved patient morbidity and survival. Our mainstay to ascites management includes changes in diet, diuretics, shunt procedures, and large volume paracentesis. The understanding of the pathophysiology of cirrhosis and portal hypertension has significantly improved in the last couple of decades but the changes in ascites management have not seemed to mirror this newer knowledge. We herein review the history of ascites management and discuss some its current limitations.
肝硬化是全球范围内发病和死亡的主要原因,肝移植是唯一可能的治愈方法。面对器官严重短缺的情况,许多患者在等待中死亡。肝硬化的一个主要并发症是门静脉高压和腹水的发生。在过去的一百年里,腹水的管理几乎没有什么进展,我们的治疗方法只有几个里程碑,但总体上显著改善了患者的发病率和生存率。我们腹水管理的主要方法包括饮食改变、利尿剂、分流手术和大量腹腔穿刺放液。在过去几十年里,对肝硬化和门静脉高压病理生理学的理解有了显著提高,但腹水管理的变化似乎并没有反映出这些新知识。我们在此回顾腹水管理的历史,并讨论其当前的一些局限性。